15: Sleep Related Breathing Disorders Flashcards
1
Q
Normal control of breathing during NREM sleep
A
- Dependence on metabolic control
- Loss of voluntary/behavioral control
- Permissive respiratory periodicity
- Alveolar hypoventilation
- VE decreased by ~1.5 Lpm
- PaCO2 increased by 3-6mmHg
- ↑upper airway resistance
2
Q
Normal control of breathing during REM sleep
A
- Decreased/absent metabolic response
- Inhibition/paralysis of postural muscles including UA and accessory breathing muscles
- Irregular, shallow respiration/apnea
- All may result in severe hypoventilation/hypoxemia
3
Q
General classification of sleep-related breathing disorders
A
- Central sleep apnea syndromes
- Due to Cheyne-Stokes breathing
- Due to drug or substance
- Obstructive sleep apnea syndromes
- Adult obstrutive sleep apnea
- Pediatric obstructive sleep apnea
- Sleep-related hypoventilation/hypoxemic syndromes
- “Central” alveolar hypoventilation syndromes
4
Q
Risks with sleep-related breathing disorders
A
- Cardiovascular:
- HTN
- HF
- Dysrhythmia
- Stroke
- Pulmonary:
- COPD
- Overlap syndrome
- Hypoventilation syndromes
- Parenchymal lung dz
- PHTN
5
Q
Apnea
A
- Cessation of airflow ≥ 10 sec
- Central, obstructive or mixed
6
Q
Hypopnea
A
- Discrete reduction (not absence) in airflow and respiratory effort
- Lasts ≥ 10 seconds
- Typically with SpO2 decrease of 3-4% and/or arousal from sleep
- Obstructive or non-obstructive
7
Q
Types of apneas
A
- Obstructive: with ventilatry effort; associated with upper airway obstruction
- Central: without ventilatory effort
- Mixed: begins with central apnea, ends as obstructive
8
Q
Sleep apnea indexes
A
- Apnea index (AI): #apneas/hr
- Apnea-hypopnea index (AHI): #apneas+hypopneas/hr
9
Q
Obstructive sleep apnea syndrome (OSAS)
A
- AHI ≥ 5 w/ excessive daytime sleepiness
- Prevalence: 24% men (30-60yo), 9% women, 80% undiagnosed
10
Q
Acute consequences of obstructive apneas
A
- Abrupt arousal from sleep
- O2 desat
- Systemic BP swings
- ↓CO
- ↑RV, LV afterload
- ↑PA pressure
- ↑myocardial O2 demand + ↓coronary blood flow
- ↑arterial stiffness
- ↑vagal, sympathetic surges
11
Q
OSA clinical manifestations
A
- Snoring alternating w/ periods of silence
- XS daytime sleepiness/increased risk of MVA
- poor sleep quality/insomnia
- awaking sensation of choking/gasping
- morning HA/dry mouth/poor memory/concentration
12
Q
OSA cardio/cerebrovascular associations
A
- Systemic HTN
- AHI 5-29.9: ≥ 20% XS risk HTN
- AHI ≥ 30: 37% XS risk HTN
- ↓LV function
- Stroke (during sleep 48% of time)
- Sudden death nocturnally
- ↑risk all-cause and CAD-related mortality
13
Q
OSA management
A
- Wt loss
- Sleep positioning (avoid supine)
- Alcohol/sedative avoidance
- Oral devices
- Surgery (?)
-
Continuous positive airway pressure (CPAP)
- pressure settings determined by titration during **polysomnography **(typically 6-16 cm H2O)
- ↑QOL, LVEF; ↓AI, AHI, daytime sleepiness; improved BP, no data on mortality
14
Q
Cheyne-Stokes Breathing with Central Sleep Apnea (CSB/CSA)
A
- Periodic breathing occurs in various disease states
- Pathogenesis:
- Stimulation of vagus nerve receptors in the lung, 2/2 pulmonary congestion or reduced lung compliance
- Hyperventilation –> hypocapnia; respiratory mechanism overresponds to CO2 –> breathing ceases, and the cycle repeats
- Increased chemoreceptor drive and delayed feedback gain
- In CHF: asphyxia, arousal, disrupted sympathovagal balance, acute systemic and pulmonary pressure responses, increased complex ventricular arrhythmias
- Treatment: Treat CHF (lower filling pressure w/ diuresis, ACE inhibitors, beta blockers, heart transplant); O2 alone (prevent SaO2 decreases, decrease apnea frequency [O2 flow must be sufficient enough to increase PaCO2]); PAP (↑intrathoracic pressure, ↓transmural pressure [↓preload, afterload]), ↓inspiratory muscle work) –> ↑PaCO2 above apneic threshold
15
Q
Central hypoventilation syndrome (CHS)
A
- Sleep-related nonobstructive alveolar hypoventilation
- “Ondine’s curse”
- Absent respiratory response to hypoxia or hypercapnia, mildly elevated PaCO2 while awake, and markedly elevated PaCO2 during non-REM sleep
- Congenital and acquired
- Infarct/reduced respiratory affernt input to dorsal respiratory group of medullary neurons, nucleus tractus solitarius